LPGAT1 is a peptide fragment reflecting motifs from lysophosphatidylglycerol acyltransferase 1, involved in lipid-modifying pathways. The sequence aids examination of substrate-binding regions and charge distribution. Researchers use it to probe conformational effects relevant to membrane-associated catalysis. Its defined composition supports structural modeling.
CAT No: ta-214
Lysophosphatidylglycerol acyltransferase 1 (LPGAT1) is an enzyme of significant interest in lipid biochemistry, particularly for its role in phospholipid remodeling. As a member of the acyltransferase family, LPGAT1 catalyzes the acylation of lysophosphatidylglycerol (LPG) to form phosphatidylglycerol (PG), a key phospholipid component of biological membranes. Its enzymatic function is crucial for maintaining membrane integrity, influencing mitochondrial dynamics, and regulating lipid signaling pathways. Researchers studying lipid metabolism, membrane biophysics, and cellular energy homeostasis frequently utilize LPGAT1 to probe the mechanisms underlying phospholipid biosynthesis and remodeling.
Enzyme activity assays: LPGAT1 is widely employed in biochemical assays designed to quantify and characterize acyltransferase activity. By incorporating this enzyme into in vitro reaction systems, investigators can monitor the conversion of lysophosphatidylglycerol substrates to their acylated products, thereby elucidating substrate specificity, kinetic parameters, and cofactor requirements. These assays are instrumental in mapping the catalytic efficiency and mechanistic properties of LPGAT1, supporting both basic research and the development of high-throughput screening protocols for acyltransferase modulators.
Lipid metabolism research: Studies of mitochondrial and cellular lipid metabolism frequently leverage LPGAT1 to dissect the pathways of phosphatidylglycerol synthesis and remodeling. Its activity is essential for understanding how cells regulate the composition and function of their membranes, particularly under physiological and stress conditions. By manipulating LPGAT1 expression or activity in model systems, researchers can investigate the impact on membrane architecture, organelle biogenesis, and lipid signaling networks, providing valuable insight into the coordination of lipid homeostasis.
Membrane biophysics and structural studies: LPGAT1 serves as a critical tool for exploring the biophysical properties of biological membranes. Its role in generating specific phospholipid species allows scientists to modulate membrane fluidity, curvature, and protein-lipid interactions in experimental systems. Structural biologists and membrane researchers utilize LPGAT1 to reconstitute defined lipid environments in vitro, facilitating the study of membrane-associated protein complexes and the elucidation of lipid-protein interplay at the molecular level.
Functional genomics and gene regulation: As a target in functional genomics, LPGAT1 enables the investigation of gene regulation networks associated with lipid biosynthesis. By employing gene editing, RNA interference, or overexpression strategies, researchers can assess the downstream effects of altered LPGAT1 activity on cellular lipid profiles and metabolic flux. These studies help clarify the regulatory circuits controlling phospholipid metabolism and identify potential genetic determinants of metabolic phenotypes.
Chemical biology and inhibitor screening: LPGAT1 is also valuable in chemical biology for the identification and characterization of small molecule modulators that influence acyltransferase activity. Screening efforts utilizing recombinant or purified LPGAT1 can reveal novel inhibitors or activators, advancing the development of research tools for dissecting lipid metabolic pathways. Such modulators provide essential probes for unraveling the physiological functions of LPGAT1 and may serve as starting points for broader studies into lipid regulatory mechanisms.
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More